Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2010

Conditions
Hepatitis B
Interventions
DRUG

Clevudine

BIOLOGICAL

Purified hepatitis B surface antigen

Trial Locations (7)

Unknown

Dankook University Hospital, Anseo-dong, Cheonan Si

Soon Chun Hyang University Cheonan Hospital, Bongmyeong-dong, Cheonan Si

The Catholic University of Korea, Daejeon St. Mary's Hospital, Daeheung-dong, Jung-gu

Chungnam National University Hospital, Daesa-dong, Jung-gu

Eulji University Hospital, Dunsan 2-dong, Seo-gu

Konyang University Hospital, Gasuwon-dong, Seo-gu,

Chungbuk National University Hospital, Gaesin-dong, Cheongju Si Heungdeok-gu

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT00501124 - Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV | Biotech Hunter | Biotech Hunter